Showing 4501-4510 of 5910 results for "".
- Alimera Exhibits Continued Growth and Expansion With New Branding and Office Relocationhttps://modernod.com/news/alimera-exhibits-continued-growth-and-expansion-with-new-branding-and-office-relocation/2480750/Alimera Sciences announced that the company has launched new corporate branding and moved its global headquarters to a new, state-of-the-art facility. Alimera refreshed its corporate brand for the first time in the company’s two-decade history to better represent its current
- Shamir Group Employees Around the World are Mobilized for Humanitarian Aid for Ukrainian Refugees in Warsawhttps://modernod.com/news/shamir-group-employees-around-the-world-are-mobilized-for-humanitarian-aid-for-ukrainian-refugees-in-warsaw/2480745/Shamir is now voluntarily operating traveling laboratories for testing and fitting of eyeglasses among Ukrainian refugees, located at the Patk Expo complex in Warsaw, Poland. The mobile laboratories on wheels are equipped with advanced technology for rapid production of advanced lenses&mdash
- Amydis Appoints Robert N. Weinreb, MD, as First Chair of Scientific Advisory Boardhttps://modernod.com/news/amydis-appoints-robert-n-weinreb-md-as-first-chair-of-scientific-advisory-board/2480742/Amydis announced the appointment of clinician scientist, Robert N. Weinreb, MD, as the First Chair to the Scientific Advisory Board of the company. “Amydis is at the forefront of developing compounds that enable retinal imaging of molecula
- Researchers Generate First Complete, Gapless Sequence of a Human Genomehttps://modernod.com/news/researchers-generate-first-complete-gapless-sequence-of-a-human-genome/2480741/Scientists have published the first complete, gapless sequence of a human genome, two decades after the Human Genome Project produced the first draft human genome sequence, according to the National Institutes of Health. According to researchers, having a complete, gap-free sequen
- Outlook Therapeutics Submits Biologics License Application to the FDA for ONS-5010 as a Treatment for Wet AMDhttps://modernod.com/news/outlook-therapeutics-submits-biologics-license-application-to-the-fda-for-ons-5010-as-a-treatment-for-wet-amd/2480738/Outlook Therapeutics announced it has submitted its biologics license application (BLA) to the FDA for ONS-5010, an investigational therapy which, if approved, will be branded as Lytenava (bevacizumab-vikg), for the treatment of wet age-related macular degeneration (AMD).&nbs
- Study: Dry Eye Disease Signs and Symptoms Significantly Reduced with Ciclosporin A 0.1% Cationic Emulsionhttps://modernod.com/news/study-dry-eye-disease-signs-and-symptoms-significantly-reduced-with-ciclosporin-a-01-cationic-emulsion/2480734/Santen EMEA has announced the results of PERSPECTIVE, a real-world evidence study evaluating the long-term treatment of severe keratitis in adult dry eye disease (DED) patients. The study, which was conducted across 44 ophthalmology clinics in 5 European countries, demonstrated that ciclosporin A
- Graybug Updates its Ophthalmic Pipeline Programshttps://modernod.com/news/graybug-updates-its-ophthalmic-pipeline-programs/2480733/Graybug Vision announced a strategic update on its pipeline programs GB-102 in wet age-related macular degeneration (AMD); GB-401, in primary open-angle glaucoma (POAG); as well as its newly acquired assets in corneal disease (GB-501); inherited retinal diseases (GB-601); and
- IAPB Introduces ‘Focus On Child Eye Health’https://modernod.com/news/iapb-introduces-focus-on-child-eye-health/2480729/Over the last few years, The International Agency for the Prevention of Blindness (IAPB) reached the world’s thought leaders with its ‘Focus On Glaucoma’ and ‘Focus On Diabetes’ series. The organization is excited to expand thi
- iSTAR Medical Announces First MINIject Surgeries Performed in the UKhttps://modernod.com/news/istar-medical-announces-first-miniject-surgeries-performed-in-the-uk/2480727/iSTAR Medical announced that it has further expanded its commercial rollout for MINIject to the UK. MINIject is iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) implant and currently the only commercially available supraciliary MIGS device. With this market exp
- Retina Consultants of America Expands Washington State Footprint Through Partnership with Retina Center Northwesthttps://modernod.com/news/retina-consultants-of-america-expands-washington-state-footprint-through-partnership-with-retina-center-northwest/2480726/Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,. Terms of the deal were not disclosed. With the addition of RCNW, RCA adds to its presence in the Pacific Northwest, and